Longterm Investors Should Be Eyeing Medivation While It’s Out of Favor
Research - – Despite post-earnings selloff, longterm outlook remains intact. MDVN is an attractive part of a core healthcare portfolio. – Off-putting 2014 Xtandi guidance may prove … Continue Reading
Premium